Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Silk Road Medical, Inc SILK NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$30.58
+11.2%

Silk Road Medical, Inc (SILK) is a Medical - Devices company in the Healthcare sector, currently trading at $27.49. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is SILK = $31 (+11.2% upside).

Financials: revenue is $177M, +33.1%/yr average growth. Net income is $56M (loss), growing at -3.7%/yr. Net profit margin is -31.5% (negative). Gross margin is 71.7% (+0 pp trend).

Balance sheet: total debt is $85M against $151M equity (Debt-to-Equity (D/E) ratio 0.56, moderate). Current ratio is 7.95 (strong liquidity). Debt-to-assets is 31.9%. Total assets: $265M.

Analyst outlook: 3 / 13 analysts rate SILK as buy (23%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 66/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).

$30.58
▲ 11.24% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Silk Road Medical, Inc, the average price target is $30.58, with a high forecast of $46.00, and a low forecast of $20.00.
Highest Price Target
$46.00
Average Price Target
$30.58
Lowest Price Target
$20.00

SILK SharesGrow Score Overview

47/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 60/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 66/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SILK

✓
VALUE Pass
60/100
SILK trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $31, implying +12.8% from the current price $27. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
SILK: +33.1%/yr revenue is, -3.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet SILK: Debt-to-Equity (D/E) ratio 0.56 (moderate), Current ratio is 7.95 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
66/100
SILK: Gross margin is 71.7% (+0 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 66/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 3 / 13 analysts rate SILK as buy (23%). Analyst consensus target is $31 (+12.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
SILK: Net profit margin is -31.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range6.08-27.51
Volume2.31M
Avg Volume (30D)2.06M
Market Cap$1.12B
Beta (1Y)1.54
Share Statistics
EPS (TTM)-1.44
Shares Outstanding$38.8M
IPO Date2019-04-04
Employees474
CEOCharles S. McKhann
Financial Highlights & Ratios
Revenue (TTM)$177.13M
Gross Profit$127.09M
EBITDA$-45.08M
Net Income$-55.74M
Operating Income$-59.27M
Total Cash$181.47M
Total Debt$84.63M
Net Debt$64.42M
Total Assets$265.31M
Price / Earnings (P/E)-19.1
Price / Sales (P/S)6.31
Analyst Forecast
1Y Price Target$29.00
Target High$46.00
Target Low$20.00
Upside+5.5%
Rating ConsensusHold
Analysts Covering13
Buy 23% Hold 54% Sell 23%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS82710M1009

Price Chart

Track all markets on TradingView
SILK
Silk Road Medical, Inc ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices
6.08 52WK RANGE 27.51

People Also View

NARI
NARI
Inari Medical, Inc.
$79.97
+0.00%
 TMDX
TMDX
TransMedics Group, Inc.
$115.68
+2.05%
 LIVN
LIVN
LivaNova PLC
$64.99
+0.63%
 AXGN
AXGN
AxoGen, Inc.
$34.46
+2.96%
 FNA
FNA
Paragon 28, Inc.
$13.09
+0.00%
 SIBN
SIBN
SI-BONE, Inc.
$14.43
+3.07%
 NPCE
NPCE
NeuroPace, Inc.
$15.35
+3.16%
 OFIX
OFIX
Orthofix Medical Inc.
$12.72
+0.55%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message